Our Clinical Sites and Trials

A5341s: Intensive Reservoir Sampling, A5321 Substudy

A5341s: A5321 Sampling Substudy   Longitudinal Sampling Substudy of A5321 is collecting information from measures of different HIV reservoirs, including…

Open and enrolling

See locations

A5321: Decay of HIV-1 Reservoirs in Participants on Long-Term Antiretroviral Therapy: The ACTG HIV Reservoirs Cohort (AHRC) Study

Studies differences and changes over time in HIV reservoirs (groups of HIV infected cells that ’hide’ from anti-HIV medications).  

Open and enrolling

Participants will be expected to stay in the study for about 7 years.

 

See locations

A5386: N-803 with or without bNAbs for HIV-1 control in participants living with HIV-1 on suppressive ART

Scientists are looking for ways to effectively clear HIV that rests in areas of the body where standard antiretroviral treatment…

Open and enrolling

Maximum of 2 years. Arm A will receive one dose of N-803 at Week 1 and then every 3 weeks for a total of eight doses.

See locations